Fenglong Bie
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Cancer-related molecular mechanisms research
Papers in
-
- Lung Cancer Treatments and Mutations 8
- Lung Cancer Diagnosis and Treatment 7
- Ferroptosis and cancer prognosis 2
- Oncology 9
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Guangyu Bai (16 shared papers)Bolun Zhou (14 shared papers)Shugeng Gao (12 shared papers)Peng Song (11 shared papers)Ruochuan Zang (10 shared papers)Moyan Zhang (9 shared papers)Yue Peng (10 shared papers)Jiajun Du (8 shared papers)
- Journals
- Future Oncology (3 papers)EBioMedicine (2 papers)Journal of Cancer (2 papers)Scientific Reports (2 papers)Molecular Cancer (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Fenglong Bie
32 papers receiving 466 citations
Peers
Comparison fields: 5 of 63
- Oncology 142
- Cancer Research 60
- Immunology 61
- Pulmonary and Respiratory Medicine 82
- Molecular Biology 122
Countries citing papers authored by Fenglong Bie
This map shows the geographic impact of Fenglong Bie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenglong Bie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenglong Bie more than expected).
Fields of papers citing papers by Fenglong Bie
This network shows the impact of papers produced by Fenglong Bie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenglong Bie. The network helps show where Fenglong Bie may publish in the future.
Co-authors
The 25 scholars most cited alongside Fenglong Bie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 55 | |
| 2 | 2022 | 53 | |
| 3 | 2022 | 31 | |
| 4 | 2022 | 30 | |
| 5 | 2019 | 30 | |
| 6 | 2019 | 28 | |
| 7 | 2018 | 24 | |
| 8 | 2022 | 21 | |
| 9 | 2019 | 20 | |
| 10 | 2019 | 18 | |
| 11 | 2021 | 16 | |
| 12 | 2023 | 15 | |
| 13 | 2019 | 14 | |
| 14 | 2023 | 13 | |
| 15 | 2022 | 11 | |
| 16 | 2021 | 11 | |
| 17 | 2021 | 11 | |
| 18 | 2019 | 10 | |
| 19 | 2024 | 9 | |
| 20 | 2019 | 9 |
About Fenglong Bie
Fenglong Bie is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Epidemiology, having authored 32 papers that have together received 470 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), RNA modifications and cancer (5 papers), Esophageal Cancer Research and Treatment (4 papers), Ferroptosis and cancer prognosis (2 papers), Ubiquitin and proteasome pathways (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Oncology (142 citations), Cancer Research (60 citations), Immunology (61 citations), Pulmonary and Respiratory Medicine (82 citations) and Molecular Biology (122 citations). Fenglong Bie has collaborated with scholars based in China and United States. Frequent co-authors include Guangyu Bai, Bolun Zhou, Shugeng Gao, Peng Song, Ruochuan Zang, Moyan Zhang, Yue Peng, Jiajun Du, Xiao Qu and Qilin Huai. Their work appears in journals such as Future Oncology, EBioMedicine, Journal of Cancer, Scientific Reports and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.